Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cartei

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Topoisomerase I, II alpha and II beta mRNA expression in peripheral blood mononuclear cells of patients with solid tumor: preliminary resultsG Cartei, A Trestin, E Colombrino, et al.
Tumori|October 31, 1988
A phase II study of mitoxantroneG Cartei, S Mian, R Cendron, et al.
Journal of the National Cancer Institute|May 19, 1993
Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancerG Cartei, F Cartei, A Cantone, et al.
Tumori|June 30, 1984
Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinomaE Ferrazzi, G L Pappagallo, O Nicoletto, et al.
Oncology|October 31, 2003
Dose finding of ifosfamide administered with a chronic two-week continuous infusionG Cartei, L Clocchiatti, C Sacco, et al.
Journal of the American Academy of Dermatology|May 1, 1993
Reduced lymphocyte subpopulations in patients with advanced or disseminated melanomaG Cartei, P G Sala, M Sanzari, et al.
Tumori|May 7, 2002
Occult small cell lung cancer associated with paraneoplastic neurologic syndrome: case reportA Bearz, B Giometto, A Freschi, et al.
Journal of Chemotherapy (Florence, Italy)|January 12, 2012
Chronic anemia due to mitomycin C is drug dose-dependent, normocytic, progressive, related to erythropoietin levels and quantitatively predictable: implications for radiochemotherapyG Cartei, E Colombrino, M C Sanzari, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinomaR Rosso, T Mazzei, A Sobrero, et al.
Cancer Treatment Reports|July 1, 1986
Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancerP De Besi, V C Sileni, L Salvagno, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Topoisomerase I, II alpha and II beta mRNA expression in peripheral blood mononuclear cells of patients with solid tumor: preliminary resultsG Cartei, A Trestin, E Colombrino, et al.
Tumori|October 31, 1988
A phase II study of mitoxantroneG Cartei, S Mian, R Cendron, et al.
Journal of the National Cancer Institute|May 19, 1993
Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancerG Cartei, F Cartei, A Cantone, et al.
Tumori|June 30, 1984
Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinomaE Ferrazzi, G L Pappagallo, O Nicoletto, et al.
Oncology|October 31, 2003
Dose finding of ifosfamide administered with a chronic two-week continuous infusionG Cartei, L Clocchiatti, C Sacco, et al.
Journal of the American Academy of Dermatology|May 1, 1993
Reduced lymphocyte subpopulations in patients with advanced or disseminated melanomaG Cartei, P G Sala, M Sanzari, et al.
Tumori|May 7, 2002
Occult small cell lung cancer associated with paraneoplastic neurologic syndrome: case reportA Bearz, B Giometto, A Freschi, et al.
Journal of Chemotherapy (Florence, Italy)|January 12, 2012
Chronic anemia due to mitomycin C is drug dose-dependent, normocytic, progressive, related to erythropoietin levels and quantitatively predictable: implications for radiochemotherapyG Cartei, E Colombrino, M C Sanzari, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinomaR Rosso, T Mazzei, A Sobrero, et al.
Cancer Treatment Reports|July 1, 1986
Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancerP De Besi, V C Sileni, L Salvagno, et al.
Pageof 10